Risk of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Addition of SGLT2 Inhibitors Versus Sulfonylureas to Baseline GLP-1RA Therapy
Chintan V. Dave(Brigham and Women's Hospital), Elisabetta Patorno(Brigham and Women's Hospital), Allison B. Goldfine(University of Colorado Denver), Robert J. Glynn(Brigham and Women's Hospital), Angela Tong(Brigham and Women's Hospital), Seoyoung C. Kim(Brigham and Women's Hospital)
Cited by 93
Related Papers
A Short Physical Performance Battery Assessing Lower Extremity Function: Association With Self-Reported Disability and Prediction of Mortality and Nursing Home Admission
|Journal of Gerontology|1994|9.7k
Clinical Update: Cardiovascular Disease in Diabetes Mellitus
|Circulation|2016|1.1k
Serum Bile Acids Are Higher in Humans With Prior Gastric Bypass: Potential Contribution to Improved Glucose and Lipid Metabolism
|Obesity|2009|590
Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections
|Annals of Internal Medicine|2019|215